List of Tables
Table 1. Global Classical Swine Fever Vaccines Market Value by Source (US$ Million), 2025 vs 2032
Table 2. Global Classical Swine Fever Vaccines Market Value by Sales Channel (US$ Million), 2025 vs 2032
Table 3. Global Classical Swine Fever Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Classical Swine Fever Vaccines Sales (M Doses) of Key Manufacturers (2021–2026)
Table 5. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Classical Swine Fever Vaccines Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Classical Swine Fever Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Classical Swine Fever Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Classical Swine Fever Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Classical Swine Fever Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Classical Swine Fever Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Classical Swine Fever Vaccines Sales by Region (M Doses), 2021–2026
Table 18. Global Classical Swine Fever Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Classical Swine Fever Vaccines Sales by Region (M Doses), 2027–2032
Table 20. Global Classical Swine Fever Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Classical Swine Fever Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Classical Swine Fever Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Classical Swine Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Classical Swine Fever Vaccines Sales by Country (M Doses), 2021–2026
Table 27. North America Classical Swine Fever Vaccines Sales by Country (M Doses), 2027–2032
Table 28. North America Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Classical Swine Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Classical Swine Fever Vaccines Sales by Country (M Doses), 2021–2026
Table 32. Europe Classical Swine Fever Vaccines Sales by Country (M Doses), 2027–2032
Table 33. Europe Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Classical Swine Fever Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Classical Swine Fever Vaccines Sales by Region (M Doses), 2021–2026
Table 37. Asia Pacific Classical Swine Fever Vaccines Sales by Region (M Doses), 2027–2032
Table 38. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Classical Swine Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Classical Swine Fever Vaccines Sales by Country (M Doses), 2021–2026
Table 42. Latin America Classical Swine Fever Vaccines Sales by Country (M Doses), 2027–2032
Table 43. Latin America Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (M Doses), 2021–2026
Table 47. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (M Doses), 2027–2032
Table 48. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2021–2026)
Table 51. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2027–2032)
Table 52. Global Classical Swine Fever Vaccines Sales Market Share by Source (2021–2026)
Table 53. Global Classical Swine Fever Vaccines Sales Market Share by Source (2027–2032)
Table 54. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Source (2021–2026)
Table 55. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Source (2027–2032)
Table 56. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2021–2026)
Table 57. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2027–2032)
Table 58. Global Classical Swine Fever Vaccines Price (US$/Dose) by Source (2021–2026)
Table 59. Global Classical Swine Fever Vaccines Price (US$/Dose) by Source (2027–2032)
Table 60. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2021–2026)
Table 61. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2027–2032)
Table 62. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2021–2026)
Table 63. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2027–2032)
Table 64. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Sales Channel (2021–2026)
Table 65. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Sales Channel (2027–2032)
Table 66. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2021–2026)
Table 67. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2027–2032)
Table 68. Global Classical Swine Fever Vaccines Price (US$/Dose) by Sales Channel (2021–2026)
Table 69. Global Classical Swine Fever Vaccines Price (US$/Dose) by Sales Channel (2027–2032)
Table 70. WINSUN Company Information
Table 71. WINSUN Description and Business Overview
Table 72. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. WINSUN Classical Swine Fever Vaccines Product
Table 74. WINSUN Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Merck Classical Swine Fever Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. CAHIC Company Information
Table 81. CAHIC Description and Business Overview
Table 82. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. CAHIC Classical Swine Fever Vaccines Product
Table 84. CAHIC Recent Developments/Updates
Table 85. Tecon Company Information
Table 86. Tecon Description and Business Overview
Table 87. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Tecon Classical Swine Fever Vaccines Product
Table 89. Tecon Recent Developments/Updates
Table 90. SPAH Company Information
Table 91. SPAH Description and Business Overview
Table 92. SPAH Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. SPAH Classical Swine Fever Vaccines Product
Table 94. SPAH Recent Developments/Updates
Table 95. Boehringer Ingelheim Company Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Boehringer Ingelheim Classical Swine Fever Vaccines Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Ceva Classical Swine Fever Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Harbin Veterinary Research Institute Company Information
Table 106. Harbin Veterinary Research Institute Description and Business Overview
Table 107. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product
Table 109. Harbin Veterinary Research Institute Recent Developments/Updates
Table 110. Qilu Animal Health Products Factory Company Information
Table 111. Qilu Animal Health Products Factory Description and Business Overview
Table 112. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product
Table 114. Qilu Animal Health Products Factory Recent Developments/Updates
Table 115. Ringpu Biology Company Information
Table 116. Ringpu Biology Description and Business Overview
Table 117. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Ringpu Biology Classical Swine Fever Vaccines Product
Table 119. Ringpu Biology Recent Developments/Updates
Table 120. DHN Company Information
Table 121. DHN Description and Business Overview
Table 122. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. DHN Classical Swine Fever Vaccines Product
Table 124. DHN Recent Developments/Updates
Table 125. CAVAC Company Information
Table 126. CAVAC Description and Business Overview
Table 127. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. CAVAC Classical Swine Fever Vaccines Product
Table 129. CAVAC Recent Developments/Updates
Table 130. Komipharm Company Information
Table 131. Komipharm Description and Business Overview
Table 132. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. Komipharm Classical Swine Fever Vaccines Product
Table 134. Komipharm Recent Developments/Updates
Table 135. Agrovet Company Information
Table 136. Agrovet Description and Business Overview
Table 137. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. Agrovet Classical Swine Fever Vaccines Product
Table 139. Agrovet Recent Developments/Updates
Table 140. Bioveta Company Information
Table 141. Bioveta Description and Business Overview
Table 142. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 143. Bioveta Classical Swine Fever Vaccines Product
Table 144. Bioveta Recent Developments/Updates
Table 145. Jinyu Bio-Technology Company Information
Table 146. Jinyu Bio-Technology Description and Business Overview
Table 147. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 148. Jinyu Bio-Technology Classical Swine Fever Vaccines Product
Table 149. Jinyu Bio-Technology Recent Developments/Updates
Table 150. Institutul Pasteur Company Information
Table 151. Institutul Pasteur Description and Business Overview
Table 152. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 153. Institutul Pasteur Classical Swine Fever Vaccines Product
Table 154. Institutul Pasteur Recent Developments/Updates
Table 155. MVP Company Information
Table 156. MVP Description and Business Overview
Table 157. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 158. MVP Classical Swine Fever Vaccines Product
Table 159. MVP Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Classical Swine Fever Vaccines Distributors List
Table 163. Classical Swine Fever Vaccines Customers List
Table 164. Classical Swine Fever Vaccines Market Trends
Table 165. Classical Swine Fever Vaccines Market Drivers
Table 166. Classical Swine Fever Vaccines Market Challenges
Table 167. Classical Swine Fever Vaccines Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Classical Swine Fever Vaccines
Figure 2. Global Classical Swine Fever Vaccines Market Value by Source (US$ Million), 2021–2032
Figure 3. Global Classical Swine Fever Vaccines Market Share by Source: 2025 & 2032
Figure 4. Tissue Culture Origin Product Picture
Figure 5. Cell Line Origin Product Picture
Figure 6. Global Classical Swine Fever Vaccines Market Value by Sales Channel (US$ Million), 2021–2032
Figure 7. Global Classical Swine Fever Vaccines Market Share by Sales Channel: 2025 & 2032
Figure 8. Government Tender
Figure 9. Market Sales
Figure 10. Global Classical Swine Fever Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Classical Swine Fever Vaccines Market Size (US$ Million), 2021–2032
Figure 12. Global Classical Swine Fever Vaccines Sales (M Doses), 2021–2032
Figure 13. Global Classical Swine Fever Vaccines Average Price (US$/Dose), 2021–2032
Figure 14. Classical Swine Fever Vaccines Report Years Considered
Figure 15. Classical Swine Fever Vaccines Sales Share by Manufacturers in 2025
Figure 16. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Classical Swine Fever Vaccines Players: Market Share by Revenue in Classical Swine Fever Vaccines in 2025
Figure 18. Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Classical Swine Fever Vaccines Sales Market Share by Country (2021–2032)
Figure 21. North America Classical Swine Fever Vaccines Revenue Market Share by Country (2021–2032)
Figure 22. U.S. Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Classical Swine Fever Vaccines Sales Market Share by Country (2021–2032)
Figure 25. Europe Classical Swine Fever Vaccines Revenue Market Share by Country (2021–2032)
Figure 26. Germany Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Classical Swine Fever Vaccines Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Classical Swine Fever Vaccines Revenue Market Share by Region (2021–2032)
Figure 33. China Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Taiwan Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Philippines Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Classical Swine Fever Vaccines Sales Market Share by Country (2021–2032)
Figure 44. Latin America Classical Swine Fever Vaccines Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Classical Swine Fever Vaccines Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. U.A.E Classical Swine Fever Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Classical Swine Fever Vaccines by Source (2021–2032)
Figure 54. Global Revenue Market Share of Classical Swine Fever Vaccines by Source (2021–2032)
Figure 55. Global Classical Swine Fever Vaccines Price (US$/Dose) by Source (2021–2032)
Figure 56. Global Sales Market Share of Classical Swine Fever Vaccines by Sales Channel (2021–2032)
Figure 57. Global Revenue Market Share of Classical Swine Fever Vaccines by Sales Channel (2021–2032)
Figure 58. Global Classical Swine Fever Vaccines Price (US$/Dose) by Sales Channel (2021–2032)
Figure 59. Classical Swine Fever Vaccines Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
